Similar findings were reported in the Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer HBV (REVEAL‐HBV) study in Taiwan, where elevated ALT levels were associated with a 5‐fold increase in HCC risk among CHB and HBV carriers [31, 32]. The gene discussed is GPT; the disease is cancer.